4//SEC Filing
Mahadevia Ankit 4
Accession 0000950170-25-112661
CIK 0001701108other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 6:04 AM ET
Size
5.2 KB
Accession
0000950170-25-112661
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2025-08-28$1.97/sh−6,572$12,947→ 703,294 total
Footnotes (2)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of restricted stock unit ("RSUs") that were granted to the Reporting Person on August 26, 2021.
- [F2]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001720974
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 6:04 AM ET
- Size
- 5.2 KB